Meloxidyl 1.5 Mg/Ml Oral Suspension

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3000.0%

Death Rate

Active Ingredients

Meloxidyl 1.5 Mg/Ml Oral Suspension

Administration Routes

OralSubcutaneous

Species Affected

Dog 8

Cat 2

Most Affected Breeds

Retriever - Labrador 2

Chihuahua 2

Maltese 1

Terrier - Yorkshire 1

Domestic Shorthair 1

Dog (unknown) 1

Bichon Frise 1

Cat (unknown) 1

Most Reported Reactions

Anorexia 4

Azotaemia 3

Lethargy (see also Central nervous system depression in 'Neurological') 2

Urinary incontinence 2

Dehydration 2

Hyperphosphataemia 2

Electrolyte disorder 2

Acute renal failure 2

Hyponatremia 2

Hypochloraemia 2

Abnormal breathing 2

Nausea 2

Outcome Breakdown

Ongoing

4 (40.0%)

Recovered/Normal

3 (30.0%)

Died

2 (20.0%)

Euthanized

1 (10.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.